← back to search

Gordon Dougan

University of Cambridge · GB
Area of research
Endocrinology · Food Science
Research interest
Professor Gordon Dougan's research focuses on the genetic analysis of host/pathogen interactions during infection, particularly those involving enteric bacteria. He has worked extensively in both academia and industry, making important contributions in the field of vaccinology where he has worked to improve vaccine delivery to poorly resourced regions.
h-index
146
citations
82,767
works
952
NIH funding
primary concept
Biology
email

Recent publications

Inter-species gene flow drives ongoing evolution of Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis
Nature Communications 2024cited by 26position: middledoi
Combining machine learning with high-content imaging to infer ciprofloxacin susceptibility in isolates of Salmonella Typhimurium
Nature Communications 2024cited by 16position: middledoi
Pulmonary inflammation in severe pneumonia is characterised by compartmentalised and mechanistically distinct sub-phenotypes
2024cited by 0position: contributordoi
A genomic appraisal of invasive Salmonella Typhimurium and associated antibiotic resistance in sub-Saharan Africa
Nature Communications 2023cited by 46position: middledoi
A global genomic analysis of Salmonella Concord reveals lineages with high antimicrobial resistance in Ethiopia
Nature Communications 2023cited by 23position: middledoi
Vaccination to Reduce Antimicrobial Resistance Burden—Data Gaps and Future Research
Clinical Infectious Diseases 2023cited by 15position: middledoi
Obesity Is Associated with Attenuated Tissue Immunity in COVID-19.
2023cited by 13position: contributordoi
Direct inference and control of genetic population structure from RNA sequencing data
Communications Biology 2023cited by 12position: middledoi
Multiplex MinION sequencing suggests enteric adenovirus F41 genetic diversity comparable to pre-COVID-19 era
Microbial Genomics 2023cited by 8position: contributordoi
Prolidase Deficiency Causes Spontaneous T Cell Activation and Lupus-like Autoimmunity.
2023cited by 4position: contributordoi
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
Nature 2022cited by 1,160position: middledoi
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
Nature 2022cited by 292position: middledoi
The international and intercontinental spread and expansion of antimicrobial-resistant Salmonella Typhi: a genomic epidemiology study
The Lancet Microbe 2022cited by 106position: middledoi
Dysregulation of macrophage PEPD in obesity determines adipose tissue fibro-inflammation and insulin resistance
Nature Metabolism 2022cited by 47position: middledoi
Paratype: a genotyping tool for Salmonella Paratyphi A reveals its global genomic diversity
Nature Communications 2022cited by 31position: middledoi
Vibrio cholerae O139 genomes provide a clue to why it may have failed to usher in the eighth cholera pandemic
Nature Communications 2022cited by 27position: middledoi
Multiplex PCR assay to detect high risk lineages of Salmonella Typhi and Paratyphi A
PLoS ONE 2022cited by 15position: middledoi
Whole genome sequence analysis of Salmonella Typhi provides evidence of phylogenetic linkage between cases of typhoid fever in Santiago, Chile in the 1980s and 2010–2016
PLoS neglected tropical diseases 2022cited by 13position: lastdoi
Genomic epidemiology of Salmonella Typhi in Central Division, Fiji, 2012 to 2016
The Lancet Regional Health - Western Pacific 2022cited by 12position: middledoi
Genetic and Structural Variation in the O-Antigen of Salmonella enterica Serovar Typhimurium Isolates Causing Bloodstream Infections in the Democratic Republic of the Congo
mBio 2022cited by 10position: middledoi
Whole genome sequence analysis of Salmonella Typhi in Papua New Guinea reveals an established population of genotype 2.1.7 sensitive to antimicrobials
PLoS neglected tropical diseases 2022cited by 8position: middledoi
Author Correction: SARS-CoV-2 evolution during treatment of chronic infection
Nature 2022cited by 6position: middledoi
Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Nature 2022cited by 3position: middledoi
Publisher Correction: Genomic reconstruction of the SARS CoV-2 epidemic in England
Nature 2022cited by 0position: middledoi
SARS-CoV-2 evolution during treatment of chronic infection
Nature 2021cited by 1,077position: middledoi
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Nature 2021cited by 713position: middledoi
A global resource for genomic predictions of antimicrobial resistance and surveillance of Salmonella Typhi at pathogenwatch
Nature Communications 2021cited by 149position: middledoi
Genomic reconstruction of the SARS-CoV-2 epidemic in England
Nature 2021cited by 118position: middledoi
Multiple introductions of multidrug-resistant typhoid associated with acute infection and asymptomatic carriage, Kenya
eLife 2021cited by 55position: lastdoi
Mapping Rora expression in resting and activated CD4+ T cells
PLoS ONE 2021cited by 43position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Stephen Baker · UPMC Hillman Cancer Center22 papers (2013–2024)Nicholas R. Thomson · University of London15 papers (2013–2024) · 12 papers (2019–2024)Zoe A. Dyson · London School of Hygiene & Tropical Medicine11 papers (2019–2022)Kathryn E. Holt · London School of Hygiene & Tropical Medicine11 papers (2013–2022) · 10 papers (2012–2021)Julian Parkhill · University of Cambridge10 papers (2012–2020)Brendan W. Wren · London School of Hygiene & Tropical Medicine8 papers (2012–2019)Trevor D. Lawley · Wellcome Sanger Institute7 papers (2012–2023)Ankur Mutreja · London School of Hygiene & Tropical Medicine6 papers (2013–2022)John D. Clemens · Korea University6 papers (2014–2021)Vanessa Wong · Department of Health6 papers (2016–2022)Mark R. Davies · London School of Hygiene & Tropical Medicine6 papers (2014–2022) · 6 papers (2012–2020) · 6 papers (2016–2022)Mailis Maes · Public Health Agency5 papers (2020–2024)Florian Marks · International Vaccine Institute5 papers (2020–2024)Thomas R. Connor · Public Health Wales5 papers (2012–2016) · 5 papers (2012–2021)Myron M. Levine · University of Leeds5 papers (2012–2022)